EGFR and neoplasm: The conjugated IR700DX also showed significantly improved long-term tumor control in a mouse EGFR-overexpressing human head/neck OSC-19-luc2-cGFP tumor model, which indicated that the targeting drug conjugation can be an effective way of improving the specific delivery of photosensitizers in the future PDT development for HNSCC.